James Norman joins Molecular Imaging, Inc. as Vice President of Sales
For the last seven years, Mr. Norman has led the commercial establishment and growth of Maccine Pte Ltd. as their global head of business development. Maccine is a leader in providing high quality non-clinical pharmacology and imaging research services. Prior to his leadership at Maccine, Mr. Norman spent eight years in increasing positions of responsibility with SNBL, Ltd., both in Japan and in the US. Mr. Norman began his working life as an animal research technician in Australia.
“James’ unique experience providing pharmaco-Imaging services globally for Maccine is an incredible springboard for Molecular Imaging’s continued growth. His leadership is exactly what the Company needs to support the next level of our development,” said Tom Ludlam, Jr., President/CEO of Molecular Imaging, Inc..
Mr. Norman will lead a team of experienced business development directors and collaborate closely with Molecular Imaging, Inc.’s operations and scientific teams as Molecular Imaging, Inc. advances the utility of pharmaco-IMAGING services to pharmaceutical and biotechnology clients globally.